Literature DB >> 3530981

Does complement kill E. coli by producing transmural pores?

J Born, S Bhakdi.   

Abstract

Three lines of evidence are presented to indicate that C5b-9 kills serum-sensitive E. coli K 12 cells by generating functional pores across the outer and inner bacterial membrane. First, viable cells carrying C5b-8 complexes are impermeable to o-nitrophenyl-beta-D-galactoside (ONPG), but lose viability and become permeable to this marker upon post-treatment with purified C9 in the absence of lysozyme. Cells killed with colicin E1 or gentamicin are also impermeable to ONPG but take up the marker if they are post-treated with lysozyme-free serum. Second, killing by C5b-9 is highly effective, deposition of only a small number of complexes being lethal. This has been demonstrated in experiments where viable cells carrying 2000-4000 C5b-7 complexes per CFU were permitted to multiply in broth culture, and the daughter generations subsequently treated with purified C8 and C9. Fifty percent killing was observed in the fifth to sixth generation, corresponding to a dilution of C5b-7 complexes to 50-100 molecules/CFU. In the presence of 2 mM EDTA, further dilution of C5b-7 down to 8-30 complexes/CFU still caused 50% killing of daughter cells. Third, treatment of C5b-7 cells with purified CC8 and C9 results in the release of intracellular K+, which commences immediately after addition of C8/C9. This was shown in experiments where C5b-7 cells were packed to high density in saline, post-treated with C8 + C9, and K+ directly measured in the cell supernatants. Based on these results, we propose that C5b-9 pores deposited in the outer bacterial membrane periodically fuse with the inner membrane, the transmural pores thus generated permitting rapid K+ efflux, with cell death ensuing through the collapse of membrane potential.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3530981      PMCID: PMC1453130     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  22 in total

1.  Mechanism of colicin action: early events.

Authors:  L Wendt
Journal:  J Bacteriol       Date:  1970-12       Impact factor: 3.490

2.  Locus of the lethal event in the serum bactericidal reaction.

Authors:  D S Feingold; J N Goldman; H M Kuritz
Journal:  J Bacteriol       Date:  1968-12       Impact factor: 3.490

3.  Killing of an encapsulated strain of Escherichia coli by human serum.

Authors:  P W Taylor; H P Kroll
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

Review 4.  The membrane channel-forming bacteriocidal protein, colicin El.

Authors:  W A Cramer; J R Dankert; Y Uratani
Journal:  Biochim Biophys Acta       Date:  1983-03-21

5.  On the cause and nature of C9-related heterogeneity of terminal complement complexes generated on target erythrocytes through the action of whole serum.

Authors:  S Bhakdi; J Tranum-Jensen
Journal:  J Immunol       Date:  1984-09       Impact factor: 5.422

6.  The ninth component of human complement: purification and physicochemical characterization.

Authors:  G Biesecker; H J Müller-Eberhard
Journal:  J Immunol       Date:  1980-03       Impact factor: 5.422

7.  Multimeric complement component C9 is necessary for killing of Escherichia coli J5 by terminal attack complex C5b-9.

Authors:  K A Joiner; M A Schmetz; M E Sanders; T G Murray; C H Hammer; R Dourmashkin; M M Frank
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

8.  Effects of colicins E1 and K on transport systems.

Authors:  K L Fields; S E Luria
Journal:  J Bacteriol       Date:  1969-01       Impact factor: 3.490

9.  Sequential metabolic expressions of the lethal process in human serum-treated Escherichia coli: role of lysozyme.

Authors:  R J Martinez; S F Carroll
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

10.  Fluorescence resonance energy transfer study of the associative state of membrane-bound complexes of complement proteins C5b-8.

Authors:  K H Cheng; T Wiedmer; P J Sims
Journal:  J Immunol       Date:  1985-07       Impact factor: 5.422

View more
  5 in total

1.  Acquired resistance of Escherichia coli to complement lysis by binding of glycophosphoinositol-anchored protectin (CD59).

Authors:  R Rautemaa; G A Jarvis; P Marnila; S Meri
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

2.  Formation of transmural complement pores in serum-sensitive Escherichia coli.

Authors:  S Bhakdi; G Kuller; M Muhly; S Fromm; G Seibert; J Parrisius
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

3.  Herpes simplex virus 1 infected neuronal and skin cells differ in their susceptibility to complement attack.

Authors:  Riina Rautemaa; Tuula Helander; Seppo Meri
Journal:  Immunology       Date:  2002-07       Impact factor: 7.397

4.  A reason for the cytolytic inefficiency of murine serum.

Authors:  F Sassi; F Hugo; M Muhly; A Khaled; S Bhakdi
Journal:  Immunology       Date:  1987-09       Impact factor: 7.397

5.  Fur is the master regulator of the extraintestinal pathogenic Escherichia coli response to serum.

Authors:  Sagi Huja; Yaara Oren; Dvora Biran; Susann Meyer; Ulrich Dobrindt; Joerg Bernhard; Doerte Becher; Michael Hecker; Rotem Sorek; Eliora Z Ron
Journal:  mBio       Date:  2014-08-12       Impact factor: 7.867

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.